Testosterone cardiovascular risk: FDA update 2025
Testosterone therapy is receiving renewed attention, not only from patients but also from regulatory agencies. In recent months, the U.S. Food and Drug Administration (FDA) updated the safety information for testosterone products, reflecting new evidence on cardiovascular risk. This has generated understandable questions among men who are considering therapy and clinicians who prescribe it.
As a urologist, I frequently meet patients who are uncertain about the safety of testosterone treatment, particularly …






![Preventing physician burnout before it begins in med school [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-4-190x100.jpg)





![Why high-quality embryos sometimes fail to implant [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-3-190x100.jpg)
